ADPT Stock Overview
A nutraceutical company, focuses on the formulation and distribution of functional mushroom products and nutritional supplement alternatives in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Adaptogenics Health Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.04 |
52 Week High | CA$0.065 |
52 Week Low | CA$0.02 |
Beta | 0 |
1 Month Change | 33.33% |
3 Month Change | 60.00% |
1 Year Change | 0% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -55.56% |
Recent News & Updates
Recent updates
Shareholder Returns
ADPT | CA Personal Products | CA Market | |
---|---|---|---|
7D | -27.3% | 1.5% | -2.6% |
1Y | 0% | 5.2% | 15.2% |
Return vs Industry: ADPT underperformed the Canadian Personal Products industry which returned 5.2% over the past year.
Return vs Market: ADPT underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility
ADPT volatility | |
---|---|
ADPT Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 10.9% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 17.4% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ADPT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine ADPT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | Daryl Ware-Lane | adaptogenicshealth.com |
Adaptogenics Health Corp., a nutraceutical company, focuses on the formulation and distribution of functional mushroom products and nutritional supplement alternatives in Canada. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
Adaptogenics Health Corp. Fundamentals Summary
ADPT fundamental statistics | |
---|---|
Market cap | CA$655.91k |
Earnings (TTM) | CA$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs ADPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ADPT income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$0 |
Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ADPT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 09:16 |
End of Day Share Price | 2024/12/16 00:00 |
Earnings | N/A |
Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Adaptogenics Health Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|